Neurolase
2 known investors
Find your way into Neurolase
764 people in our graph share verified history with the Neurolase team — schools, employers, funds. One of them is your warm intro.
Crystal Huangunlockedknows Monika Kott · together at Harvard University (overlapped)
×2knows the team · via Imperial College London
knows the team · via The London School of Economics and Political Science (LSE)
×3knows the team · via Rothschild
×2knows the team · via Harvard University
knows the team · via Independent Advisory
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
Founders & leadership
MK
Monika KottinCo-Founder & CEOShe has background in commercial advisory and investment focused on AI applications in healthcare, medtech, and biotech.
BV
Babar VaqasinCo-Founder & CMOBabar Vaqas is a neurosurgeon trained at Oxford University, Cambridge, and London who holds a PhD from Imperial College London focused on brain tumor surgery. He specializes in neuro-oncology and minimally invasive surgical techniques, with experience in clinical trial design for emerging medical technologies.
Investors · 2
In the news
Frequently asked questions
- What does Neurolase do?
- Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
- Who founded Neurolase?
- Neurolase was founded by Monika Kott, Babar Vaqas.
- Who are Neurolase's investors?
- Neurolase's investors include Oxford Technology Management, Zinc.